Leveraging real-world Data from administrative claims and medical records to inform safety and effectiveness of piperacillin-tazobactam in the Management of Pediatric Hospital Acquired Pneumonia.

Autor: Blumenstock JA; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, USA., Faerber JA; Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Menon M; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, USA., Lawler R; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, USA., Downes KJ; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, USA., Kratz E; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, USA., Erickson K; Cancer and Blood Disorders Center, Oncology, Seattle Children's, Seattle, Washington, USA., Haltzman-Cassenti B; Patient Services, MDGroup, Durham, North Carolina, USA., Yildirim I; Yale Institute for Global Health, New Haven, Connecticut, USA.; Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, Connecticut, USA., Hussaini L; Pediatric Infectious Diseases, Emory School of Medicine, Atlanta, Georgia, USA., Elmontser M; Anatomic & Clinical Pathology, St. Louis University, St. Louis, Missouri, USA., Sederdahl BK; Department of Pediatrics, Emory University, Atlanta, Georgia, USA., Hahn A; Division of Infectious Diseases, Children's National Hospital, Washington, DC, USA.; Center for Genetic Medicine Research, Children's National Research Institute, Washington, DC, USA.; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC, USA., Thomson J; Division of Hospital Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA., Newland J; Department of Pediatrics, Washington University School of Medicine, St. Louis, St. Louis, Missouri, USA., Terrill C; Department of Pediatrics, Washington University School of Medicine, St. Louis, St. Louis, Missouri, USA., Bradley J; Department of Pediatrics, Division of Infectious Diseases, University of California at San Diego, La Jolla, California, USA.; Division of Infectious Diseases, Rady Children's Hospital San Diego, San Diego, California, USA., Zachariah P; Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA., Younus M; Safety Surveillance Research, Pfizer, Collegeville, Pennsylvania, USA., Mo J; Safety Surveillance Research, Pfizer, Collegeville, Pennsylvania, USA., Wible M; Global Product Development, Pfizer, Collegeville, Pennsylvania, USA., Tawadrous M; Global Product Development, Pfizer, Collegeville, Pennsylvania, USA., Fisher BT; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, USA.; Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Publikováno v: American journal of epidemiology [Am J Epidemiol] 2024 Aug 06. Date of Electronic Publication: 2024 Aug 06.